Reply: Comment on 'Histopathologic evaluation of liver metastases from colorectal cancer patients treated with FOLFOXIRI plus bevacizumab'

Br J Cancer. 2013 Dec 10;109(12):3129-30. doi: 10.1038/bjc.2013.652. Epub 2013 Oct 24.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / pathology*
  • Female
  • Humans
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / secondary*
  • Male

Substances

  • Antibodies, Monoclonal, Humanized